The bill amends Ontario’s Gift of Life Act to permit hospitals to publicly identify deceased organ or tissue donors by name in memorials or other forms of appreciation when specific conditions are met. The change inserts a targeted exception into section 11, allowing identification “in accordance with subsection (3)” and then sets four requirements: name-only disclosure, memorial-purpose, a six-month delay after the transplant, and consent from the appropriate substitute decision-maker.
This is a limited, statutory carve‑out from the Act’s general confidentiality framework intended to let hospitals honor donors while attempting to protect recipient and family privacy. For hospitals, transplant programs and substitute decision‑makers it creates a new authorization pathway and operational steps — and for privacy officers it creates new risk points around re‑identification, consent verification and recordkeeping.
At a Glance
What It Does
The bill amends section 11 of the Gift of Life Act to add a new subsection permitting public identification of deceased organ or tissue donors where four conditions are met: only the deceased’s name may be disclosed; the disclosure must be for hospital memorial or appreciation purposes; at least six months must have passed since the transplant; and consent for the public identification must be obtained from the relevant substitute decision‑maker. The amendment also modifies subsection 11(1)’s introductory wording to allow identification in accordance with the new subsection.
Who It Affects
Public hospitals and their transplant programs, hospital communications and memorial committees, substitute decision‑makers for deceased donors, and privacy/compliance officers who oversee donor confidentiality policies will be directly affected. The change also touches donor registries and organ procurement coordinators who manage donor records and consent documentation.
Why It Matters
The bill formalizes a recognition practice that many hospitals have handled informally, embedding statutory limits intended to protect recipient confidentiality while enabling public thanks. That combination of recognition plus explicit constraints creates new operational duties (timing, consent verification, limited disclosure) and legal exposure if hospitals misapply the narrow exception.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The Robbie’s Legacy Act adds a narrowly framed exception to the Gift of Life Act so that hospitals may publicly identify deceased organ or tissue donors by name as part of a memorial or other expression of appreciation. The change applies only to deceased donors for whom consent for donation was given under the Act (either the donor’s own consent or consent by a substitute).
It does not alter any other confidentiality provisions except to allow this specified public identification.
The exception includes four concrete limits. First, the identity disclosed must be only the deceased person’s name; no additional identifying facts — expressly including the transplant date — may be published.
Second, the disclosure must serve the purpose of recognizing the donor in a memorial or a form the hospital decides is appropriate. Third, the hospital must wait at least six months after the transplant linked to the donor’s consent before making the public identification.
Fourth, consent for the public identification and the specific manner of doing so must be obtained from the appropriate substitute decision‑maker: if the deceased previously gave consent, the substitute who would act under subsection 5(2) at the time of the identification must give this consent; if the deceased’s substitute originally gave the donation consent, that same substitute must give consent for the public identification.Functionally, the bill converts what has been a matter of practice into statutory authority while constraining disclosure to reduce potential harms to recipients and families. It leaves hospitals with discretion over the memorial’s form but imposes a chain-of-consent and a timing threshold that will require policy updates, recordkeeping changes and staff training to ensure compliance.
The Five Things You Need to Know
The bill adds subsection 11(3) to the Gift of Life Act creating an explicit exception allowing hospitals to publicly identify deceased organ or tissue donors by name only.
Hospitals may only make such public identifications for the purpose of recognition — a memorial or any other form the hospital considers appropriate — not for publicity or fundraising.
The bill requires a waiting period of at least six months after the transplant associated with the donor’s consent before public identification may occur.
Consent for the public identification must come from the appropriate substitute decision‑maker: if the deceased personally consented, the substitute who would act at the time must consent; if a substitute initially consented to donation, that same substitute must consent to identification.
The bill also amends the opening wording of section 11(1) to permit identifications made in accordance with the new subsection (3), creating a limited statutory carve‑out from the Act’s general confidentiality restriction.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Creates a statutory exception hook for donor identification
The bill rewrites the opening phrase of section 11(1) to shift from an absolute ‘Except where legally required’ to ‘Except in accordance with subsection (3) or where legally required.’ That change is mechanical but important: it creates a specific legal pathway for hospitals to identify donors, rather than leaving any memorial practice to implicit policy or administrative discretion. Practically, this reduces the risk that hospitals are operating outside statutory authority when they publicly honour donors, but it also narrows what counts as lawful identification to what the new subsection permits.
Sets four gatekeeping conditions for public identification
The new subsection lays out the full set of conditions under which a deceased person may be publicly identified as a donor. It is not open-ended: the text chains together a purpose limitation (recognition), an information limitation (name only), a timing requirement (six‑month delay), and a consent requirement tied to the Act’s donor/substitute consent framework. For implementation this means hospitals must verify each element before any public naming, turning an administrative or communications decision into a compliance checkpoint.
Limits the published information to the donor’s name
This clause allows only the deceased’s name to be used and explicitly bans additional identifying information, citing the transplant date as an example. The construction intends to protect recipient privacy and reduce re‑identification risk, but it is narrowly defined—hospitals will need policies to interpret what other details (e.g., hospital unit, donor age, community identifiers) are barred and to avoid inadvertent disclosures that together could identify the recipient.
Restricts purpose to memorials and imposes a six‑month delay
Subclause (2) confines public identification to recognition in the form of a memorial or any other form the hospital chooses, signaling broad institutional discretion over format but not over purpose. Subclause (3) establishes the six‑month waiting period after the transplant connected to the donor’s consent. Operationally, hospitals must map donor records to transplant dates and build a calendar or workflow to ensure the minimum delay before any public naming.
Tie‑back to donor/substitute consent rules and who must approve identification
This clause specifies whose consent is required for the public identification and links it to existing consent rules in subsections 4(1) and 5(2). If the donor personally consented while alive, the person who would be the substitute decision‑maker at the time of identification must give permission; if a substitute originally consented, that same substitute must approve the public naming. This creates a clear but potentially cumbersome verification task for hospitals and raises practical questions when a substitute changes or is unavailable.
Immediate commencement on Royal Assent
The bill provides that it comes into force on the day it receives Royal Assent. There is no delayed implementation window or phased roll‑out, so hospitals and transplant programs would need to update policies and staff practice promptly after assent.
Formal short title
The bill names itself the Robbie’s Legacy Act (Honouring Beloved Organ and Tissue Donors), 2025. The short title has no legal effect on operations but is how the amendment will be referenced in future statutory citations and policy guidance.
This bill is one of many.
Codify tracks hundreds of bills on this topic across all five countries.
Explore this topic in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Donor families and substitute decision‑makers — they get statutory permission for public recognition of a loved one, which institutionalizes a way to commemorate donation and may provide emotional closure.
- Hospitals and transplant programs — the bill gives explicit legal authority to create memorials and recognition programs, reducing the risk of acting outside the Gift of Life Act and allowing institutions to incorporate donor recognition into communications and donor relations policies.
- Potential future donors and public awareness efforts — codifying memorialization may make donation more visible and socially valued, which could support recruitment and public trust in donation programs if implemented sensitively.
Who Bears the Cost
- Hospitals (administration and compliance) — they must verify transplant dates, track six‑month windows, document substitute consent for public identification, and train staff, creating administrative and communications burdens.
- Substitute decision‑makers and families — they carry the decision burden of consenting (or declining) public identification after a traumatic event and may face external pressure to permit public naming.
- Privacy/compliance officers and legal counsel — they must resolve ambiguous disclosure edges (what counts as identifying information), create policy guardrails to prevent re‑identification, and manage any complaints or legal risks that arise from memorials.
- Transplant recipients — while the statute focuses on donors, recipients face an increased re‑identification risk if name‑only disclosures are combined with other data or local knowledge, potentially exposing sensitive health information.
Key Issues
The Core Tension
The bill’s central dilemma is legitimate recognition versus confidential care: it authorizes hospitals to honour donors publicly to reinforce social value and provide closure for families, but every public identification increases the risk of revealing sensitive health information about transplant recipients or exposing families to unwanted attention; the statute tries to thread the needle with name‑only, timing and consent rules, but these measures cut both ways — they enable memorialization while creating practical, privacy and verification challenges that have no perfect technical fix.
The bill balances recognition against confidentiality through bright‑line elements, but several implementation gaps create real risks. The ‘name‑only’ rule reduces direct disclosure but does not eliminate re‑identification risk, especially in small communities or when a hospital pairs the name with dates, service lines, or donor stories.
The statute lists transplant date as an example of prohibited identifying information, but it does not define a complete set of barred data points or give hospitals clear guidance on aggregations of otherwise innocuous facts that, together, identify a recipient.
The consent requirement ties decision‑making to the existing donor/substitute framework, which is administratively tidy but practically brittle. The bill requires the substitute who ‘‘would be’’ in place at the time of consent if the donor personally consented; that raises questions about how hospitals determine who that person is, how to proceed if the substitute cannot be located, or if family disputes arise.
The immediate commencement provision amplifies these operational challenges: hospitals will need to modify policies and educate staff quickly, yet the bill does not create implementation resources, model consent forms, or reporting requirements to audit compliance.
Finally, the Act leaves enforcement and sanctions unaddressed. It permits an activity rather than prescribing penalties for misuse, so disputes over what constitutes an acceptable memorial, or liability for inadvertent disclosures, will need to be resolved through existing privacy complaints processes or litigation.
The legislative text also does not explicitly reconcile this new exception with other legal duties toward recipient confidentiality under provincial health records law or common‑law duties, leaving room for interpretive conflict.
There's more to this law than the bill.
Codify Laws traces every connection across the legislative lifecycle.